These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2686125)

  • 21. Detection of drug resistance markers for chloroquine and pyrimethamine-sulfadoxine in Jazan area, Saudi Arabia using PCR and restriction digestion.
    Al Harthi SA
    J Egypt Soc Parasitol; 2007 Apr; 37(1):17-30. PubMed ID: 17580565
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Within-Host Selection of Drug Resistance in a Mouse Model of Repeated Incomplete Malaria Treatment: Comparison between Atovaquone and Pyrimethamine.
    Nuralitha S; Siregar JE; Syafruddin D; Roelands J; Verhoef J; Hoepelman AI; Marzuki S
    Antimicrob Agents Chemother; 2016 Jan; 60(1):258-63. PubMed ID: 26503662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphisms associated with sulphadoxine-pyrimethamine drug resistance among Plasmodium falciparum field isolates in malaria endemic areas of Assam.
    Sharma J; Dutta P; Khan SA; Soni M; Dey D; Mahanta J
    J Postgrad Med; 2015; 61(1):9-14. PubMed ID: 25511211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rare, highly pyrimethamine-resistant alleles of the Plasmodium falciparum dihydrofolate reductase gene from 5 African sites.
    Bates SJ; Winstanley PA; Watkins WM; Alloueche A; Bwika J; Happi TC; Kremsner PG; Kublin JG; Premji Z; Sibley CH
    J Infect Dis; 2004 Nov; 190(10):1783-92. PubMed ID: 15499534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug resistance to sulphadoxine-pyrimethamine in Plasmodium falciparum malaria in Mlimba, Tanzania.
    Mbugi EV; Mutayoba BM; Malisa AL; Balthazary ST; Nyambo TB; Mshinda H
    Malar J; 2006 Oct; 5():94. PubMed ID: 17076899
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of pyrimethamine resistance in two different strains of Plasmodium berghei.
    van Dijk MR; McConkey GA; Vinkenoog R; Waters AP; Janse CJ
    Mol Biochem Parasitol; 1994 Nov; 68(1):167-71. PubMed ID: 7891743
    [No Abstract]   [Full Text] [Related]  

  • 27. Short report: molecular markers associated with Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in the Democratic Republic of Congo.
    Cohuet S; Bonnet M; Van Herp M; Van Overmeir C; D'Alessandro U; Guthmann JP
    Am J Trop Med Hyg; 2006 Jul; 75(1):152-4. PubMed ID: 16837723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Markers of sulfadoxine-pyrimethamine-resistant Plasmodium falciparum in placenta and circulation of pregnant women.
    Mockenhaupt FP; Bedu-Addo G; Junge C; Hommerich L; Eggelte TA; Bienzle U
    Antimicrob Agents Chemother; 2007 Jan; 51(1):332-4. PubMed ID: 17088491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Origins and spread of novel genetic variants of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates in Indonesia.
    Basuki S; Fitriah ; Risamasu PM; Kasmijati ; Ariami P; Riyanto S; Hidayat A; Susilowati D; Iskandar ; Armika B; Budiono ; Dachlan YP; Kanbara H; Uemura H
    Malar J; 2018 Dec; 17(1):475. PubMed ID: 30558597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roles of specific Plasmodium falciparum mutations in resistance to amodiaquine and sulfadoxine-pyrimethamine in Burkina Faso.
    Dokomajilar C; Lankoande ZM; Dorsey G; Zongo I; Ouedraogo JB; Rosenthal PJ
    Am J Trop Med Hyg; 2006 Jul; 75(1):162-5. PubMed ID: 16837725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parasitological rebound effect and emergence of pyrimethamine resistance in Plasmodium falciparum after single-dose sulfadoxine-pyrimethamine.
    Marks F; von Kalckreuth V; Kobbe R; Adjei S; Adjei O; Horstmann RD; Meyer CG; May J
    J Infect Dis; 2005 Dec; 192(11):1962-5. PubMed ID: 16267768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome comparison of progressively drug resistant Plasmodium falciparum lines derived from drug sensitive clone.
    Toteja R; Nair L; Bhasin V
    Mem Inst Oswaldo Cruz; 2001 Apr; 96(3):427-33. PubMed ID: 11313656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
    Djaman AJ; Basco LK; Mazabraud A
    Sante; 2002; 12(4):363-7. PubMed ID: 12626289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population-based validation of dihydrofolate reductase gene mutations for the prediction of sulfadoxine-pyrimethamine resistance in Uganda.
    Talisuna AO; Langi P; Mutabingwa TK; Watkins W; Van Marck E; Egwang TG; D'Alessandro U
    Trans R Soc Trop Med Hyg; 2003; 97(3):338-42. PubMed ID: 15228255
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular surveillance of drug-resistance associated mutations of Plasmodium falciparum in south-west Tanzania.
    Schönfeld M; Barreto Miranda I; Schunk M; Maduhu I; Maboko L; Hoelscher M; Berens-Riha N; Kitua A; Löscher T
    Malar J; 2007 Jan; 6():2. PubMed ID: 17224049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Contribution of molecular genetics to the understanding of chemoresistance of Plasmodium falciparum].
    Le Bras J; Basco LK; Cremer G; Charmot G
    Bull Soc Pathol Exot; 1992; 85(2):146-9. PubMed ID: 1356539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intercontinental spread of pyrimethamine-resistant malaria.
    Roper C; Pearce R; Nair S; Sharp B; Nosten F; Anderson T
    Science; 2004 Aug; 305(5687):1124. PubMed ID: 15326348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women.
    Tinto H; Ouédraogo JB; Zongo I; van Overmeir C; van Marck E; Guiguemdé TR; D'Alessandro U
    Am J Trop Med Hyg; 2007 Apr; 76(4):608-13. PubMed ID: 17426157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common origin and fixation of Plasmodium falciparum dhfr and dhps mutations associated with sulfadoxine-pyrimethamine resistance in a low-transmission area in South America.
    McCollum AM; Mueller K; Villegas L; Udhayakumar V; Escalante AA
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2085-91. PubMed ID: 17283199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
    Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
    Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.